Oftaquix (Levofloxacin Hemihydrate)

Levofloxacin Hemihydrate, the active ingredient in Oftaquix, is a fluoroquinolone antibiotic presented as a strength/form for oral use. It treats a variety of bacterial infections in adults and children when appropriate. GNH USA supplies Oftaquix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oftaquix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oftaquix is a fluoroquinolone that targets bacterial pathogens in several organ systems.

- Community‑acquired pneumonia: helps ​​​​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​  reduces bacterial load and improves respiratory symptoms. - Acute bacterial sinusitis: alleviates sinus inflammation and infection by eradic ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​  eliminating ​ ​ ​​​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​ - Uncomplicated urinary tract infection: clears the causative uropathogens, relieving dysuria and frequency. - Skin and soft‑tissue infections: reduces bacterial proliferation in cellulitis and wound infections. - Acute exacerbation of chronic bronchitis: improves airflow and reduces bacterial burden in the lower respiratory tract.

Levofloxacin, like other fluoroquinolones, may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: watery stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional vertiginous sensations. - Photosensitivity: increased skin reaction to sunlight.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles, often linked to sudden strain. - QT‑interval prolongation: may predispose to cardiac arrhythmias. - Central nervous system effects: seizures or severe confusion. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Hepatotoxicity: elevated liver enzymes or jaundice. - Clostridioides difficile infection: antibiotic‑associated colitis.

When using Levofloxacin, clinicians should consider several safety aspects.

- Tendon toxicity: avoid use in patients with recent tendon injury or corticosteroid therapy. - QT prolongation risk: monitor patients with cardiac history or electrolyte disturbances. - Renal impairment: dose adjustment may be required in reduced kidney function. - Pregnancy and lactation: avoid unless benefits outweigh risks; limited safety data. - Age considerations: use caution in the elderly due to higher risk of adverse events. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Levofloxacin can interact with several medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect, raising bleeding risk. - NSAIDs (e.g., ibuprofen): heightened risk of central nervous system stimulation.

Moderate Interactions (Monitor Closely): - Diabetic agents (e.g., insulin, sulfonylureas): may cause hypoglycaemia. - Theophylline: increased serum concentrations leading to toxicity. - Corticosteroids: combined use may raise tendon‑rupture risk. - Cyclosporine: potential for increased nephrotoxicity. - Oral contraceptives: possible reduction in contraceptive effectiveness.